Nanobiotix Newswire

Comprehensive Real-Time News Feed for Nanobiotix.

Results 1 - 20 of 41 in Nanobiotix

  1. Recent Study: Brain Tumor - Pipeline Review, H2 2014Read the original story

    Monday Jul 21 | SBWire

    ... from pipeline Companies Mentioned in this Report: Chong Kun Dang Pharmaceutical Corp., Pfizer Inc., Bayer AG, Nanobiotix, Hutchison MediPharma Limited, Siena Biotech S.p.A., Oncovir, Inc., DEKK-TEC, Inc., SignPath Pharma Inc, CalAsia ...

    Comment?

  2. Small Cap Share Tips: Nanobiotix secures funding to fight cancerRead the original story w/Photo

    Monday Jul 14 | Daily Mail

    ... star performing technology stocks. The year to date has been one of incredible progress for Euronext-listed Nanobiotix with the advances reflected in a share price that has appreciated 200 per cent in that short time. The group, whose technology ...

    Comment?

  3. Small Cap Movers: Proteome Sciences shares' receive welcome boost...Read the original story w/Photo

    Friday Jul 11 | Daily Mail

    ... for making arthritis treatment Humira, is stalking Dublin-based Shire with a view to pulling off a tax inversion Nanobiotix, which is developing a significant advance on traditional radiotherapy, told investors revenues for the quarter were a 48,596 ...

    Comment?

  4. Nanobiotix Revenue For The 2nd Quarter Of 2014Read the original story

    Friday Jul 11 | BioSpace

    In EUR Q2 2014 H1 2014 Q2 2013 ----------- ------- ------- ------- Revenues 48,596 93,939 48,569 Of which : License 45,847 91,190 45,847 Services 2,749 2,749 2,722 ------------ ------- ------- ------- The revenue recorded by NANOBIOTIX during the second quarter of 2014 relates to the upfront payment from the Taiwan-based PharmaEngine within the ... (more)

    Comment?

  5. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Jul 3 | Business Wire

    ... Issue Westpac Banking Corporation - Series 1098 USD 25,000,000 FRN due April 2016 ISIN Nu... )--Regulatory News: Nanobiotix (Paris:NANO): Place de cotation : Euronext Paris Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  6. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Jul 3 | Business Wire

    ... Issue Westpac Banking Corporation - Series 1098 USD 25,000,000 FRN due April 2016 ISIN Nu... )--Regulatory News: Nanobiotix (Paris:NANO): Place de cotation : Euronext Paris Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  7. Nanotechnology: A rare metal that enhances radiotherapyRead the original story

    Jun 27, 2014 | Financial Times

    ... element, with just a few minor applications in the electronics and nuclear industries. Now a French company, Nanobiotix, is introducing hafnium to medicine for the first time, in the form of a product that enhances the impact of radiotherapy in ...

    Comment?

  8. Nanoparticle Drug Delivery Market Investigated by Kuick Research in...Read the original story

    Jun 18, 2014 | PRWeb

    ... maceuticals, Alnylam Pharmaceuticals, Arrowhead Research, BIND Biosciences, iCeutica, NanoCarrier, Nippon Kayaku, Nanobiotix and Samyang.

    Comment?

  9. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jun 17, 2014 | Business Wire

    This report provides the key credit metrics for 46 Mexican corporates that ... )--The development of a tender option bond structure that complies with the Volcker rule paves the way for tax-exempt money market funds to remain a buyer of municipal... )--Regulatory News: NANOBIOTIX , sociA tA franA aise pionniA re en nanomA decine ... (more)

    Comment?

  10. ASCO Recap: Leaning in at the Plate, Swinging for the FencesRead the original story w/Photo

    Jun 17, 2014 | Bioscience Technology

    ... and the following is a summary of some of the more interesting players that made it on base: - Manufactured by Nanobiotix, of Paris, France, NBTXR3 is a nanoparticle formulation of hafnium oxide crystals. Hafnium is a heavy metal normally used in ...

    Comment?

  11. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jun 5, 2014 | Business Wire

    ... has announced the addition of the "Facial Aesthetics Market to 2020 - Economic Re... )--Regulatory News: Nanobiotix (Paris:NANO): Place de cotation : Euronext Paris de Nyse Euronext Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  12. NanobiotixRead the original story

    May 26, 2014 | UB Reporter

    ... nanomedicine into real-world products for patients battling cancer. In February, Levy's drug development company, Nanobiotix, announced that a cancer treatment called NBTXR3, the first product from its NanoXray pipeline, had shown positive ...

    Comment?

  13. Nanobiotix Presents Successful Phase I Results For Its Lead...Read the original story

    Jun 2, 2014 | BioSpace

    NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced the successful completion of the first in human study of its lead NanoXray product, NBTXR3, which will be presented today at the American Society of Clinical Oncology annual meeting Help employers find you! Check out all the ... (more)

    Comment?

  14. NanobiotixRead the original story

    May 26, 2014 | UB Reporter

    ... nanomedicine into real-world products for patients battling cancer. In February, Levy's drug development company, Nanobiotix, announced that a cancer treatment called NBTXR3, the first product from its NanoXray pipeline, had shown positive ...

    Comment?

  15. Nanobiotix looks to bring cancer treatment to marketRead the original story

    May 26, 2014 | PhysOrg Weblog

    ... nanomedicine into real-world products for patients battling cancer. In February, Levy's drug development company, Nanobiotix, announced that a cancer treatment called NBTXR3, the first product from its NanoXray pipeline, had shown positive ...

    Comment?

  16. UB spinoff Nanobiotix looks to bring cancer treatment to marketRead the original story w/Photo

    May 23, 2014 | University at Buffalo

    ... nanomedicine into real-world products for patients battling cancer. In February, Levy's drug development company, Nanobiotix, announced that a cancer treatment called NBTXR3, the first product from its NanoXray pipeline, had shown positive ...

    Comment?

  17. "Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2014" PublishedRead the original story

    May 16, 2014 | SBWire

    ... and Company, GlaxoSmithKline plc, MedImmune, LLC, Celltrion, Inc., Novartis AG, Eisai Co., Ltd., ImmunoGen, Inc., Nanobiotix SA, Acceleron Pharma, Inc., Virttu Biologics Limited, Ascenta Therapeutics, Inc., Jennerex Biotherapeutics, Inc., Onconova ...

    Comment?

  18. Soft Tissue Sarcoma - Pipeline Review, H1 2014Read the original story

    May 15, 2014 | SBWire

    ... Biotech Inc. Topotarget A/S CytRx Corporation Threshold Pharmaceuticals, Inc. MabVax Therapeutics, Inc. Nanobiotix SA Morphotek, Inc. GP Pharm, S.A. MolMed S.p.A. Pharma Mar, S.A. TRACON Pharmaceuticals, Inc. Jiangsu Chia-tai Tianqing Pharmaceutical ...

    Comment?

  19. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    May 12, 2014 | Business Wire

    ... and asset management company, today announced that it has sold One Alewife Center ... )--Regulatory News : NANOBIOTIX (Paris:NANO) (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine ...

    Comment?

  20. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Apr 30, 2014 | Business Wire

    ... composition as of March 31, 2014. Investment Objective: The Fund's investment objectiv... )--Regulatory News: NANOBIOTIX (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine dA veloppant ...

    Comment?